Search results

Evidence-based recommendations on aflibercept (Eylea) for treating sight problems caused by diabetic macular oedema in adults.

Result type

Technology appraisal guidance

Published

22 July 2015

Evidence-based recommendations on ombitasvir–paritaprevir–ritonavir (also known as Viekirax) with or without dasabuvir (also known as Exviera) for adults with some types (called genotypes) of chronic hepatitis C.

Result type

Technology appraisal guidance

Published

25 November 2015

Evidence-based recommendations on empagliflozin (Jardiance) in combination therapy for treating type 2 diabetes.

Result type

Technology appraisal guidance

Published

25 March 2015

Evidence-based recommendations on apixaban (Eliquis) for treating and preventing recurrent deep vein thrombosis or pulmonary embolism in adults.

Result type

Technology appraisal guidance

Published

4 June 2015

Evidence-based recommendations on everolimus (Certican) for preventing organ rejection in adults having a liver transplant.

Result type

Technology appraisal guidance

Published

22 July 2015

Evidence-based recommendations on aflibercept solution for injection (Eylea) for treating wet age-related macular degeneration in adults.

Result type

Technology appraisal guidance

Published

24 July 2013

Evidence-based recommendations on living-donor liver transplantation. This involves replacing a diseased or damaged liver with a healthy one from a living human donor.

Result type

Interventional procedures guidance

Published

25 November 2015

Evidence-based recommendations on vedolizumab (Entyvio) for previously treated moderately to severely active Crohn’s disease in adults.

Result type

Technology appraisal guidance

Published

26 August 2015

Evidence-based recommendations on insertion of an epiretinal prosthesis for retinitis pigmentosa. This involves inserting an implant into the eye that receives data from a small camera on the person's glasses and then stimulates healthy cells in the retina to see basic images.

Result type

Interventional procedures guidance

Published

26 June 2015

Evidence-based recommendations on edoxaban (Lixiana) for preventing stroke and systemic embolism in adults with non-valvular atrial fibrillation.

Result type

Technology appraisal guidance

Last updated

2 July 2021

Evidence-based recommendations on ceftazidime with avibactam for treating severe drug-resistant gram-negative bacterial infections....

Result type

Health technology evaluation

Published

17 August 2022